Draper Esprit Aktie 30782172 / GB00BY7QYJ50
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
29.10.2025 08:00:17
|
Notice of Half Year Results Presentations
|
Molten Ventures Plc (GROW)
29 October 2025 Molten Ventures plc Notice of Half Year Results Presentations Molten Ventures (LSE: GROW), a leading venture capital firm investing in and developing high-growth digital technology businesses, announces details of presentations to accompany its half year results for the six months ended 30 September 2025 being announced on Tuesday, 25 November 2025.
A presentation for analysts and other registered investment professionals will be held at 09:30am GMT on Tuesday, 25 November 2025, both in-person at Molten’s London office and virtually. To register to attend in-person, please contact Sodali on molten@sodali.com. To register to attend virtually, please visit: https://stream.brrmedia.co.uk/broadcast/68fb4c429f0c7e00132b04c4
Molten will also be hosting a presentation on Friday, 5 December 2025 at 10:30am GMT via the Investor Meet Company platform. The presentation is open to all existing and potential shareholders, with a live Q&A session. Questions can be submitted pre-event via the Investor Meet Company dashboard or at any time during the presentation. Investors can sign up for the event for free via this link: https://www.investormeetcompany.com/molten-ventures-plc/register-investor
Enquiries:
Molten Ventures is a leading venture capital firm in Europe, developing and investing in high growth technology companies. It invests across four sectors: Enterprise & SaaS; AI, Deeptech & Hardware; Consumer Technology; and Digital Health with highly experienced partners constantly looking for new opportunities in each. Listed on the London Stock Exchange, Molten Ventures provides a unique opportunity for public market investors to access these fast-growing tech businesses, without having to commit to long term investments with limited liquidity. Since its IPO in June 2016, Molten has deployed over £1bn capital into fast growing tech companies and has realised more than £700m to 30 September 2025. For more information, go to https://investors.moltenventures.com/investor-relations/plc
Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. |
| ISIN: | GB00BY7QYJ50 |
| Category Code: | NOR |
| TIDM: | GROW |
| LEI Code: | 213800IPCR3SAYJWSW10 |
| OAM Categories: | 3.1. Additional regulated information required to be disclosed under the laws of a Member State |
| Sequence No.: | 406479 |
| EQS News ID: | 2220074 |
| End of Announcement | EQS News Service |
|
|
Nachrichten zu Draper Esprit PLC
|
08:00 |
Transaction in Own Shares (EQS Group) | |
|
29.10.25 |
Notice of Half Year Results Presentations (EQS Group) | |
|
29.10.25 |
Transaction in Own Shares (EQS Group) | |
|
28.10.25 |
Transaction in Own Shares (EQS Group) | |
|
24.10.25 |
Holding(s) in Company (EQS Group) | |
|
24.10.25 |
Transaction in Own Shares (EQS Group) | |
|
23.10.25 |
Transaction in Own Shares (EQS Group) | |
|
23.10.25 |
Half Year Trading Update (EQS Group) |
Etienne Jornod (OM Pharma): Führung, Erfolg & Pharma-Strategie- zu Gast im BX Morningcall
Im BX Morning Call spricht die Schweizer Unternehmer-Ikone Etienne Jornod (OM Pharma) mit François Bloch und Olivia Hähnel (BX Swiss) über Führung, Wachstum, Kooperationen, seine Zeit bei der NZZ und darüber, warum Zuhören der wichtigste Leadership-Skill ist.
Die perfekte Folge für alle, die sich für Pharmastrategien, Galenica/Vifor und Unternehmertum interessieren.
🎯 Themen im Interview mit Etienne Jornod (OM Pharma)
– Antrieb und Führungsphilosophie eines Unternehmers
– Erfolgsweg von Galenica – Lehren aus Jahrzehnten Führung
– Frauenquote, Teamkultur und Leadership bei OM Pharma
– Internationale Expansion: China, USA und neue Märkte
– Forschung, Druck und Verantwortung in der Pharmaindustrie
– Inspiration, Balance und persönliche Haltung zum Erfolg
– Zukunftsvisionen: Schweiz, Unternehmertum und Investments
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Aktien in diesem Artikel
| Draper Esprit PLC | 5.50 | 0.00% |
|
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Nach EZB-Zinsentscheid: SMI und DAX letztlich wenig bewegt -- Märkte in Fernost zum Handelsende uneinsAm heimischen sowie am deutschen Aktienmarkt hielten sich Anleger zurück. Die wichtigsten asiatischen Börsen wiesen am Donnerstag verschiedene Vorzeichen aus.